| 1 |
32277401 | Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis. | 2020 May |
1 |
| 2 |
31041232 | A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus. | 2019 Mar |
2 |
| 3 |
30815552 | Slope of change in HbA1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. | 2018 Apr |
1 |
| 4 |
27539604 | Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects. | 2017 Jan |
1 |
| 5 |
28294488 | Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial). | 2017 Aug |
1 |
| 6 |
28982699 | Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM). | 2017 Nov |
2 |
| 7 |
26749407 | Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin. | 2016 May |
1 |
| 8 |
24308786 | Canagliflozin versus glimepiride treatment in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU trial). | 2014 Jan |
1 |
| 9 |
15936468 | Efficacy of glimepiride in Japanese type 2 diabetic subjects. | 2005 Jun |
1 |